Our Experience in the Management of Therapeutic Failures of Fractures of the Proximal End of the Femur (About 35 Cases)
1 other identifier
observational
35
1 country
1
Brief Summary
Osteosyntheses employed in treating fractures at the upper end of the femur play a critical role in facilitating a swift recovery by minimizing immobilization periods and enabling early rehabilitation of the affected joints, thereby promoting a speedy return to normal walking function. Osteosynthesis alters the mechanical dynamics of the bone segment, which undergoes continual changes during the consolidation and mobilization phases of recovery. Throughout these stages, a range of mechanical complications may arise, posing challenges despite the successful prevention of infections. Non-infectious complications associated with the presence of osteosynthesis materials, especially in weight-bearing areas like the lower limb, remain a concern. In light of these considerations, surgeons must exercise meticulous care in selecting synthetic materials to mitigate the risk of osteosynthesis failures. In cases where internal fixation fails, the standard recourse often involves converting to total hip arthroplasty (THA). However, it is essential to note that THA subsequent to complications arising from proximal femur osteosynthesis presents a higher incidence of both intraoperative and postoperative complications compared to the implantation of primary total hip prostheses. Thus, while osteosynthesis remains a valuable intervention for femur fractures, careful attention to material selection and postoperative management is crucial in optimizing patient outcomes and minimizing complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2021
CompletedFirst Submitted
Initial submission to the registry
March 28, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedApril 11, 2024
April 1, 2024
6.9 years
March 28, 2024
April 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Surgical Approach
type of approach
from enrollment to the of treatment 6 years
Preparation of the Patient
type of preparation
from enrollment to the of treatment 6 years
Anesthesia
type of anesthesia
from enrollment to the of treatment 6 years
Type of Surgical Revision
material implanted for revision
from enrollment to the of treatment 6 years
Types of Prosthesis
prothesis used
from enrollment to the of treatment 6 years
Secondary Outcomes (4)
Age Distribution
from enrollment to the end of treatment 6 years
Distribution by Sex
from enrollment to the end of treatment 6 years
Distribution According to Affected Side
from enrollment to the end of treatment 6 years
Distribution According to Circumstances of Trauma
from enrollment to the end of treatment 6 years
Study Arms (1)
cases of recurrent fractures of the proximal end of the femur following surgical treatment failure
Interventions
Eligibility Criteria
cases of recurrent fractures of the proximal end of the femur following surgical treatment failure
You may qualify if:
- Diagnosis of a fracture of the proximal end of the femur.
- Subsequent surgical intervention(s) due to failure of initial surgical treatment
You may not qualify if:
- Those initially treated with total hip arthroplasty.
- Patients lost to follow-up, not consistently monitored, or untreated after diagnosis of the complication.
- Cases with incomplete medical records
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IBN jazzar hospital
Kairouan, 3190, Tunisia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 28, 2024
First Posted
April 11, 2024
Study Start
January 1, 2015
Primary Completion
December 1, 2021
Study Completion
December 2, 2021
Last Updated
April 11, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
use for other resaerchs